Prostate Cancer Research
Funding research to increase survival and find a cure for men with advanced prostate cancer
News Centre

Research Updates

All, PCR News, Research Updates

Leading cancer charities team up to tackle the spread of breast and prostate cancers to the bones

27 January 2026
Leading cancer charities team up to tackle the spread of breast and prostate cancers to the bones
Research Updates

Looking at the impact of Social Identities and Demographic factors on the Quality of Life for those living beyond cancer

6 December 2024
Looking at the impact of Social Identities and Demographic factors on the Quality of Life for those living beyond cancer
Research Updates

Exploring the relationship between childhood adversity and prostate cancer

7 October 2024
Exploring the relationship between childhood adversity and prostate cancer
Research Updates

Scottish Medical Consortium approves Olaparib for use in NHS Scotland

14 March 2024
Scottish Medical Consortium approves Olaparib for use in NHS Scotland
Research Updates

NICE issues Final Draft Guidance recommending Lynparza (Olaparib) with abiraterone for patients with untreated hormone-relapsed metastatic prostate cancer

21 December 2023
NICE issues Final Draft Guidance recommending Lynparza (Olaparib) with abiraterone for patients with untreated hormone-relapsed metastatic prostate cancer
Research Updates

Government announces major prostate cancer screening trial to end needless prostate deaths

21 November 2023
Government announces major prostate cancer screening trial to end needless prostate deaths
Research Updates

Pluvicto™ Update

30 October 2023
Pluvicto™ Update
Research Updates

Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland

9 October 2023
Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland
Research Updates

Exploring men’s psychological adjustment to prostate cancer

8 August 2023
Exploring men’s psychological adjustment to prostate cancer
Research Updates

NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer

18 May 2023
NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer
Research Updates

NICE reopens Pluvicto consultation

2 March 2023
NICE reopens Pluvicto consultation
All, PCR News, Research Updates

Predicting which cancers will return

24 February 2023
Predicting which cancers will return
Load more
Press enter or esc to cancel